BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 12464312)

  • 1. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
    Crocker PR
    Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglecs in the immune system.
    Crocker PR; Varki A
    Immunology; 2001 Jun; 103(2):137-45. PubMed ID: 11412300
    [No Abstract]   [Full Text] [Related]  

  • 3. Siglecs, sialic acids and innate immunity.
    Crocker PR; Varki A
    Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
    Sgroi D; Nocks A; Stamenkovic I
    J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
    Kelm S; Pelz A; Schauer R; Filbin MT; Tang S; de Bellard ME; Schnaar RL; Mahoney JA; Hartnell A; Bradfield P
    Curr Biol; 1994 Nov; 4(11):965-72. PubMed ID: 7533044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease.
    McMillan SJ; Crocker PR
    Carbohydr Res; 2008 Aug; 343(12):2050-6. PubMed ID: 18279844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sialoadhesins--a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily.
    Kelm S; Schauer R; Crocker PR
    Glycoconj J; 1996 Dec; 13(6):913-26. PubMed ID: 8981082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin.
    Sgroi D; Varki A; Braesch-Andersen S; Stamenkovic I
    J Biol Chem; 1993 Apr; 268(10):7011-8. PubMed ID: 8463234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic and clinical immunology of Siglecs.
    von Gunten S; Bochner BS
    Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New I-type lectins of the CD 33-related siglec subgroup identified through genomics.
    Crocker PR; Zhang J
    Biochem Soc Symp; 2002; (69):83-94. PubMed ID: 12655776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis.
    Zhang M; Varki A
    Glycobiology; 2004 Nov; 14(11):939-49. PubMed ID: 15240561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siglecs and their roles in the immune system.
    Crocker PR; Paulson JC; Varki A
    Nat Rev Immunol; 2007 Apr; 7(4):255-66. PubMed ID: 17380156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siglecs as targets for therapy in immune-cell-mediated disease.
    O'Reilly MK; Paulson JC
    Trends Pharmacol Sci; 2009 May; 30(5):240-8. PubMed ID: 19359050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
    Engel P; Wagner N; Miller AS; Tedder TF
    J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.
    Nath D; van der Merwe PA; Kelm S; Bradfield P; Crocker PR
    J Biol Chem; 1995 Nov; 270(44):26184-91. PubMed ID: 7592823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs.
    Brinkman-Van der Linden EC; Sjoberg ER; Juneja LR; Crocker PR; Varki N; Varki A
    J Biol Chem; 2000 Mar; 275(12):8633-40. PubMed ID: 10722703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.